Cytek Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $201.5 | $200.5 | $193.0 | $164.0 | $128.0 |
| Operating income | -$40.4 | -$20.5 | -$27.8 | -$1.8 | $9.2 |
| Net income | -$66.5 | -$6.0 | -$12.1 | $2.5 | $3.0 |
| Balance Sheet | |||||
| Total debt | $0.5 | $1.1 | $1.6 | $2.3 | $0.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$8.8 | $21.9 | $0.6 | -$22.0 | $0.3 |
| Share repurchases | $15.1 | $21.6 | $44.2 | $0.0 | $0.0 |
Shares outstanding 129.1M · Free float 89.4%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.